At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Brain Involvement in Myotonic Dystrophy Type I: From Functional Neuroimaging to the Impact on Quality of Life
In Brief
An observational study for Myotonic Dystrophy Type 1 (DM1). Completed, enrolled 50 participants.
Detailed Summary
This project aims to characterize DM1 patients, by collecting clinical, neuropsychological, neuroimaging, and molecular rehabilitative data, in order to elucidate the etiology of cognitive troubles, with special attention to the impact of those dysfunctions on quality of life.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMyotonic Dystrophy Type 1 (DM1)
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2012
Primary CompletionJun 2015
First PostedJul 2018
TodayJul 2026
First PostedJul 18, 2018
Enrollment StartJul 3, 2012
Primary CompletionJun 4, 2015
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 8.0 years ago